GUTS
Price
$1.91
Change
-$0.05 (-2.56%)
Updated
Jun 18, 04:59 PM (EDT)
Capitalization
93.55M
56 days until earnings call
RCKT
Price
$2.82
Change
+$0.10 (+3.68%)
Updated
Jun 18, 04:59 PM (EDT)
Capitalization
304.9M
54 days until earnings call
Interact to see
Advertisement

GUTS vs RCKT

Header iconGUTS vs RCKT Comparison
Open Charts GUTS vs RCKTBanner chart's image
Fractyl Health
Price$1.91
Change-$0.05 (-2.56%)
Volume$5.02K
Capitalization93.55M
Rocket Pharmaceuticals
Price$2.82
Change+$0.10 (+3.68%)
Volume$132.9K
Capitalization304.9M
GUTS vs RCKT Comparison Chart in %
Loading...
GUTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GUTS vs. RCKT commentary
Jun 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GUTS is a Hold and RCKT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 19, 2025
Stock price -- (GUTS: $1.95 vs. RCKT: $2.72)
Brand notoriety: GUTS and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GUTS: 69% vs. RCKT: 88%
Market capitalization -- GUTS: $93.55M vs. RCKT: $304.9M
GUTS [@Biotechnology] is valued at $93.55M. RCKT’s [@Biotechnology] market capitalization is $304.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $335.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GUTS’s FA Score shows that 0 FA rating(s) are green whileRCKT’s FA Score has 1 green FA rating(s).

  • GUTS’s FA Score: 0 green, 5 red.
  • RCKT’s FA Score: 1 green, 4 red.
According to our system of comparison, both GUTS and RCKT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GUTS’s TA Score shows that 4 TA indicator(s) are bullish while RCKT’s TA Score has 5 bullish TA indicator(s).

  • GUTS’s TA Score: 4 bullish, 4 bearish.
  • RCKT’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, RCKT is a better buy in the short-term than GUTS.

Price Growth

GUTS (@Biotechnology) experienced а -9.72% price change this week, while RCKT (@Biotechnology) price change was -13.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.14%. For the same industry, the average monthly price growth was +7.14%, and the average quarterly price growth was +2.05%.

Reported Earning Dates

GUTS is expected to report earnings on Aug 13, 2025.

RCKT is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (-3.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCKT($305M) has a higher market cap than GUTS($93.5M). GUTS YTD gains are higher at: -5.340 vs. RCKT (-78.361). GUTS has higher annual earnings (EBITDA): -95.83M vs. RCKT (-246.03M). RCKT has more cash in the bank: 318M vs. GUTS (42.1M). RCKT has less debt than GUTS: RCKT (25.4M) vs GUTS (61.4M). GUTS has higher revenues than RCKT: GUTS (60K) vs RCKT (0).
GUTSRCKTGUTS / RCKT
Capitalization93.5M305M31%
EBITDA-95.83M-246.03M39%
Gain YTD-5.340-78.3617%
P/E RatioN/AN/A-
Revenue60K0-
Total Cash42.1M318M13%
Total Debt61.4M25.4M242%
FUNDAMENTALS RATINGS
RCKT: Fundamental Ratings
RCKT
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GUTSRCKT
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
71%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 10 days ago
83%
Bullish Trend 16 days ago
80%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GUTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ADGCX15.69N/A
N/A
AB Core Opportunities C
RSVIX14.07N/A
N/A
RBC Small Cap Value I
TEMPX8.73N/A
N/A
Nuveen Emerging Markets Eq Prem
ANVMX10.20N/A
N/A
American Century Non-US Intrs ValR6
NYVRX27.65-0.29
-1.04%
Davis NY Venture R

GUTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GUTS has been loosely correlated with ADPT. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if GUTS jumps, then ADPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GUTS
1D Price
Change %
GUTS100%
-5.34%
ADPT - GUTS
35%
Loosely correlated
-1.46%
SCPH - GUTS
34%
Loosely correlated
N/A
RCKT - GUTS
33%
Loosely correlated
-5.56%
GLUE - GUTS
32%
Poorly correlated
-5.19%
IPSC - GUTS
32%
Poorly correlated
+1.41%
More

RCKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCKT has been loosely correlated with SVRA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if RCKT jumps, then SVRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCKT
1D Price
Change %
RCKT100%
-5.56%
SVRA - RCKT
61%
Loosely correlated
-6.42%
PRTA - RCKT
54%
Loosely correlated
+0.71%
AXON - RCKT
52%
Loosely correlated
-0.39%
DNLI - RCKT
51%
Loosely correlated
-4.17%
VCYT - RCKT
47%
Loosely correlated
+0.45%
More